Sandrine Chamayou
Sant'Agata Li Battiati, 95030, Italy
NCT Number: NCT02820415
Oocyte accumulation by vitrification is a valid strategy to increase the number of available embryos for biopsy and the number of viable euploid embryos to transfer after preimplantation genetic testing.
Looking for future studies?
Notify Me28 year–43 year
Female
Observational
Sant'Agata Li Battiati, 95030, Italy
In the present study, the investigators considered the hypothesis to accumulate vitrified oocytes with a view to increasing the number of oocytes for micro-injection and consequently the number of blastocyst to diagnose for patients with normal ovarian reserve and candidate for PGT. The partecipants were proposed to undergo several cycles of ovarian stimulation. In the first cycles, mature (metaphase II) oocytes were vitrified and consequently accumulated. In the last cycle, the freshly produced mature oocytes and the previously accumulated ones were micro-injected together with the same partner's semen sample. PGT was performed on blastocysts produced from the two sources of oocytes. The comprehensive chromosomal analysis of biopsied trophectoderm cells was performed using NGS technology. The number of available euploid blastocyst and the proportion of euploid/aneuploidy embryos from fresh and vitrified/warmed oocytes were compared. In conclusion the investigators evaluated the efficacy of oocyte accumulation by vitrification in increasing the number of available embryos for biopsy and the number of viable euploid embryos to transfer after PGT.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Time frame: 1 year
from fresh and vitrified/warmed oocytes
Unità di Medicina della Riproduzione, Italy
Other
Oocyte Accumulation by Vitrification is a Valid Strategy to Increase the Number of Euploid Available Embryos for Biopsy and Transfer After Preimplantation Genetic Testing
Acronym: PGSvitfreov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01661010
Aneuploidy, Cardiovascular Abnormalities
Bethesda, Maryland, United States
View Trial DetailsNCT02006446
Aneuploidy, Chromosome Aberrations
Lille, France
View Trial DetailsNCT05488236
Aneuploidy, Chromosome Aberrations
Lisbon, Portugal
View Trial DetailsNCT06801652
Aneuploidy, Blastocyst
Oradea, Bihor County, Romania
View Trial Details